Hims & Hers Health Options Spot-On: On November 22nd, 119.74K Contracts Were Traded, With 644.77K Open Interest
Unusual Options Activity: BNS, XP and Others Attract Market Bets, BNS V/OI Ratio Reaches 166.7
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
Hims & Hers Health Shares Rise Thursday Amid Extension of FDA Decision
Hims & Hers Health Expands Board With New Appointment
Citi Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Raises Target Price to $24
Hims & Hers Health Options Spot-On: On November 21st, 99,200 Contracts Were Traded, With 627.89K Open Interest
Express News | Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...
Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed
Hold Rating on Hims & Hers Health Amidst Regulatory Uncertainty and Market Risks
Express News | Hims & Hers Launches Meal Replacement Bars And Shakes To Enhance Personalized Weight Loss Plans, Offering Comprehensive Nutrition Support For Customers Starting At $110/Month
Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys
Hims & Hers Health Options Spot-On: On November 20th, 101K Contracts Were Traded, With 584.45K Open Interest
Will Amazon Bury Hims Stock or Should You Buy the Dip?
TD Cowen Reiterates Buy on Hims & Hers Health, Maintains $28 Price Target
Hims & Hers Health Analyst Ratings
TD Cowen Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $28
Hims & Hers Health Insider Sold Shares Worth $1,236,364, According to a Recent SEC Filing
Hims & Hers Health Options Spot-On: On November 19th, 113.07K Contracts Were Traded, With 563.7K Open Interest
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Celcuity (CELC)